Paper

Aryl quinolinyl hydrazone derivatives as anti-inflammatory agents that inhibit TLR4 activation in the macrophages.

Published Jun 15, 2019 · Utsab Debnath, S. Mukherjee, N. Joardar

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Aryl quinolinyl hydrazone derivatives show promising anti-inflammatory properties, with compound 3e inhibiting TLR4 signaling pathway in macrophages.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Aryl quinolinyl hydrazone derivatives as anti-inflammatory agents that inhibit TLR4 activation in the macrophages.

References

Citations